-
Media
The Sidra Medicine Media Center is regularly updated. Here you can catch up on current events, read stories from patients who had their lives changed by Sidra Medicine, and contact us with any questions you may have about our medical services.
Study Day on Innovation in Women's Health
Program Brochure
|
Activity Title |
Study Day on Innovations in Women’s Health |
|
Date |
7 September 2024 |
|
Venue |
Sidra Medicine, Al Luqta street, Doha, Qatar and Teams Platform |
|
Facilitators |
Dr Hala Abdullahi and Dr Gbemisola Okunoye |
|
Target Audience |
The study dayon innovation in women’s health is designed to meet the learning and knowledge needs of healthcare providers in Obstetrics and Gynecology, from primary care to tertiary level, including but not limited to the following groups:
|
|
Overall Learning Objectives |
At the end of the Study Day on Innovations in women’s health, delegates should be able to:
|
Program Overview
|
08:00-08:20 |
Registration |
|
|
SESSION 1: Chairs: Dr Hala Abdullahi and Dr Gbemisola Okunoye |
|
08:20-08:30 |
Welcome and Opening remarks. Dr Gbemisola Okunoye |
|
08:30-08:55 |
What can we do better in Obesity management? Dr Ibrahim Ibrahim, Consultant Endocrinologist, Sidra Medicine |
|
08:55- 09:20 |
Generative Artificial Intelligence (AI) use in clinical practice-where are we now? Dr. Ehab Said Hamed - Consultant Family Medicine Operations - HC Qatar University |
|
09:20-09:45 |
Virtual reality (VR) in undergaduate medical education: the Qatar experience Dr Caitlin Huckell and Dr Moune Jaber |
|
09:45-10:10 |
New Insights and Applications in Cord Blood Banking Dr Chiara Cugno |
|
10:10-10:25 |
Q & A |
|
10:25 -10:45 |
Coffee break |
|
|
SESSION 2: Chairs: Dr Yassin and Dr Varsha |
|
10:45 -11:10 |
The Impact of AI on Diagnostic imaging and other updates Dr Kadria El Haddad, Consultant Radiologist, Sidra Medicine |
|
11:10-11:35 |
The use of image fusion in Prenatal Medicine Dr Medhat Alberry, Senior attending Physician, MFM, Sidra Medicine |
|
11:35 -12:00 |
Femtech and the use of AI in Reproductive Medicine and assisted conception Dr Spyros Chouliaras, Attending Physician, RMU, Sidra Medicine |
|
12:00-12:25 |
Controversies, Consensus and Advances in the Management of Fibroids Dr Pradeep Jayaram, Senior Attending Physician, O &G, Al-Khor Hospital, HMC |
|
12:25-12:40 |
Q & A |
|
12:40-13: 25 |
Lunch Break |
|
13:25-16:00 |
SESSION 3: Chairs: Dr Khwla and Dr Ashok |
|
13:25-13:50 |
Personal use of health technology Applications and self-examination kits-what should we advise women? Dr Deepa Subramanian, Attending Physician, O & G, Sidra Medicine |
|
13:50 - 14:15 |
Integrating Multiomics and Artificial Intelligence to Predict Gestational Diabetes: Preliminary results from the Omouma study Dr Souhaila, Director- Perinatal and Reproductive Health Division, Sidra Medicine |
|
14:15 - 14:40 |
PPH management devices: innovative solutions for an old problem! Dr Rudaina Hassan, Attending Physician, O & G, Sidra Medicine |
|
14:40 - 14:50 |
Q & A |
|
14:50-15:15
15:40-15:55 |
Clinical Debate: Motion: AI will become superior to humans in the overall delivery of healthcare| Against: Dr Osric Navti , Senior attending physician, FMU, Alwakra Hospital, HMC Rebuttal- For and Against |
|
15:55-16:00 |
Closing remarks and End of Day Dr Hala Abdullahi |
“This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 6 hours for Category 1”
|
In support of improving patient care, Sidra Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Scientific Planning Committee has reviewed all disclosed relevant relationships of speakers, moderators, facilitators, and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest. |
|
|